Less than two years after he started as Laboratory Director for the United States Equestrian Federation, a former official responsible for drug testing Pennsylvania Thoroughbreds is no longer employed by the Federation. Dr. Cornelius Uboh, former Bureau Director at the Pennsylvania Equine Toxicology and Research Laboratory, took over the USEF Equine Research and Testing Laboratory
By: US Equestrian Communications Department Lexington, Ky. – On Tuesday, July 25, the US Equestrian Federation (USEF) Board of Directors voted to approve the phase I recommendations of the USEF Medroxyprogesterone Acetate (MPA) Panel on the continued investigation, research, and analysis of the use of MPA, commonly referred to as Depo-Provera®, in competition horses. The panel
By: Press Release For almost 10 years, Equioxx® (firocoxib) has been the only coxib non-steroidal anti-inflammatory drug (NSAID) approved for use in horses. Now, this once-daily treatment to control joint pain and inflammation associated with equine osteoarthritis, is approved by the FDA in tablet form, and will be available in the market early fall. Equioxx is
SIGN UP TO RECEIVE RMTC COMMUNICATIONS
Quick Links
Sign up to receive RMTC communications:
Sign up to receive RMTC communications:
